CuraTeQ Biologics Secures ANVISA Approval for Hyderabad Biosimilars Manufacturing Facility
CuraTeQ Biologics has received ANVISA GMP approval for its Hyderabad biosimilars manufacturing facility, strengthening its global regulatory credentials and enabling expanded supply of biosimilar products to Brazil and the wider Latin American market.
World Health Organisation | 22/07/2026 | By News Bureau | 160
The World Health Organisation has issued its first recommendation on doxycycline Post-Exposure Prophylaxis (doxyPEP) for preventing bacterial STI, marking a significant step towards expanding evidence-based STI prevention options for vulnerable populations.
World Health Organisation | 30/05/2026 | By News Bureau | 108
WHO, WTO and WCO Update Global Customs Codes to Fast-Track Vaccine Shipments by 2028
New customs codes under HS 2028 aim to improve global tracking and faster clearance of vaccines and essential medical supplies during health emergencies.
World Health Organisation | 04/02/2026 | By News Bureau | 211
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy